Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Athenex, Inc. (ATNX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 91,730,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for cancer treatment. Co.'s platforms are: Oncology Innovation Platform, which is focused on the research and development of its proprietary drugs; Commercial Platform, which is focused on the sales and marketing of its drugs and the market development of its proprietary drugs; and Global Supply Chain Platform, which provides supply of active pharmaceutical ingredients for its clinical and commercial efforts. Co.'s clinical pipeline in the Oncology Innovation Platform is derived from Cell Therapy, Orascovery, based on a P-glycoprotein pump inhibitor, and Src Kinase inhibition.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 30,000
Total Buy Value $0 $0 $0 $13,319
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 371
  Page 9 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2020-03-12 4 B $8.19 $16,380 D/D 2,000 137,048 2.74     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2020-03-12 4 B $8.12 $16,240 D/D 2,000 3,101,959 3.15     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2020-03-12 4 B $8.35 $33,396 D/D 4,000 3,099,959 3.23     -
   Yordon Jeffrey See Remarks   •       –      –    2020-03-12 4 B $8.14 $81,430 D/D 10,000 218,926 2.74     -
   Fok Manson Director   –       •      –    2020-03-11 4 B $10.28 $513,850 D/D 50,000 1,919,609 2.39     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2020-03-09 4 B $9.79 $19,573 D/D 2,000 135,048 2.74     -
   Edelman Joseph 10% Owner   –       –       •   2019-12-24 4 B $14.39 $1,060,514 I/I 73,698 11,532,467 1.5     -
   Edelman Joseph 10% Owner   –       –       •   2019-12-23 4 B $14.30 $2,191,289 I/I 153,237 11,458,769 1.5     -
   Edelman Joseph 10% Owner   –       –       •   2019-12-20 4 B $14.14 $2,677,013 I/I 189,322 11,305,532 1.5     -
   Edelman Joseph 10% Owner   –       –       •   2019-12-19 4 B $13.72 $3,635,484 I/I 263,743 11,116,210 1.5     -
   Wu Jinn Director   –       •      –    2019-12-18 4 OE $4.55 $91,000 D/D 20,000 371,208     -
   Sze Randoll Chief Financial Officer   •       –      –    2019-12-17 4 B $13.25 $13,250 D/D 1,000 4,000 2.74     -
   Wu Jinn Director   –       •      –    2019-12-16 4 OE $4.55 $136,500 D/D 30,000 351,208     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2019-12-16 4 OE $4.55 $68,250 D/D 15,000 3,095,959     -
   Fok Manson Director   –       •      –    2019-11-07 4 B $11.67 $583,500 D/D 50,000 1,869,609 2.39     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2019-10-22 4 OE $4.55 $22,750 D/D 5,000 3,080,959     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2019-10-21 4 OE $4.55 $45,500 D/D 10,000 3,075,959     -
   Edelman Joseph 10% Owner   –       –       •   2019-10-17 4 B $10.93 $546,500 I/I 50,000 10,852,467 1.5     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2019-10-17 4 OE $4.55 $45,500 D/D 10,000 3,065,959     -
   Sze Randoll Chief Financial Officer   •       –      –    2019-10-17 4 B $10.99 $10,990 D/D 1,000 3,000 2.74     -
   Edelman Joseph 10% Owner   –       –       •   2019-10-16 4 B $10.29 $691,714 I/I 67,222 10,802,467 1.5     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2019-10-16 4 B $10.16 $60,960 D/D 6,000 3,055,959 3.23     -
   Sze Randoll Chief Financial Officer   •       –      –    2019-09-30 4 B $12.62 $12,620 D/D 1,000 2,000 2.74     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2019-09-27 4 B $12.85 $38,550 D/D 3,000 3,049,959 3.23     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •       •   2019-09-23 4 B $13.86 $69,300 D/D 5,000 3,046,959 3.23     -

  371 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed